Swedencare (SECARE.ST) Stock Analysis & AI Equity Report
Swedencare (SECARE.ST) overview
Swedencare (SECARE.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, Swedencare reported revenue of SEK 2,695m and operating profit of SEK 142m; the year-end share price was 38.40 SEK and market capitalisation was SEK 6,129m. Swedencare is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Swedencare's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-27. Data will be refreshed during report generation.
About Swedencare
Swedencare AB (publ) develops, produces, and sells premium pet health products for dogs, cats, and horses. Its portfolio includes dental care, supplements, topicals, treats, and veterinary-formulated products under brands such as ProDen PlaqueOff®, NaturVet®, Innovet, Pet MD®, Rx Vitamins®, and others. The company sells through veterinarians, pet stores, and online channels across international markets.
Generate the Swedencare report
Swedencare is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Swedencare and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.